Cannabinoid Receptor CB2 Subtype: A Novel Pharmacological Target in Cancer and Neurodegenerative Diseases
Journal: Open Access Journal of Pharmaceutical Research (Vol.3, No. 2)Publication Date: 2019-05-15
Authors : Contino M; Giampietro R;
Page : 1-3
Keywords : Cannabinoid receptor; Neurodegenerative diseases; Cancer;
Abstract
CB2 receptor (CB2R) is one of the canonical cannabinoid receptor belonging to endocannabinoid system (ECS). It was cloned for the first time in 1993 from the human leukemia cell line HL-60, and it is part of the G- protein coupled receptors family (GPCRs), being coupled to a Gi/o protein [
Other Latest Articles
Last modified: 2023-07-12 19:06:13